Japan Artificial Organs Bionic Implants Market by Types (Bionics [Cardiac Bionics, Orthopedic Bionics, Vision Bionics, and Others] and Artificial Organs [Cochlear Implants, Artificial Lungs, Artificial Kidneys, Artificial Hearts, and Others]), Methods of Fixation (Externally Worn and Implantable), Technology (Electronic and Mechanical), Applications (Clinical Research Institutions, Hospitals, and Others), and Country - Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028
The Japan artificial organs bionic implants market size is anticipated to expand at a considerable CAGR during the forecast period, 2021–2028. The growth of the market is attributed to organ failure is more common among the elderly or age-related ailments, which drives the market growth.
Artificial organs and bionic implants are developed medical devices that can be worn on the outside or implanted. Artificial organs are inserted into the body to replace the original organs if the original organ fails and if any organ is destroyed by an external event, such as an accident. Severe blood loss, drug addiction, significant trauma, and other acute disorders are among the most common causes of organ failure. Furthermore, unhealthy lifestyles including poor eating habits, smoking, drinking too much alcohol, and not exercising enough are also major causes of organ failure.
Implantable devices with electrical and mechanical components are referred to as bionic implants. They can be divided into two categories: electronics and biological. Additionally, they are upgraded robotic technologies. Biomaterials, which are manmade substances that connect with biological processes utilized for medical purposes, are used to make artificial organs and bionic implants.
Market Trends, Drivers, Restraints, and Opportunities
- Several vehicle accidents, injuries, and consequent disabilities are projected to propel the market growth in the coming years.
- Rising significantly number of patients waiting for organ transplants is a key factor spurring the market expansion during the forecast period.
- High price of machines and systems, as well as the threat of compatibility problems and failures, is estimated to impede the market growth.
- Increasing technological advances and increased government support are anticipated to create immense opportunities for the market players.
Scope of the Report
The report on the Japan artificial organs bionic implants market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
Japan Artificial Organs Bionic Implants Market - Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2020 |
|
Historic Data |
2018–2019 |
|
Forecast Period |
2021–2028 |
|
Segmentation |
Types (Bionics [Cardiac Bionics, Orthopedic Bionics, Vision Bionics, and Others] and Artificial Organs [Cochlear Implants, Artificial Lungs, Artificial Kidneys, Artificial Hearts, and Others]), Methods of Fixation (Externally Worn and Implantable), Technology (Electronic and Mechanical), and Applications (Clinical Research Institutions, Hospitals, and Others) |
|
Country |
Japan |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
Ossur; Medtronic; Getinge AB.; Cyberonics, Inc.; Cochlear Ltd.; Boston Scientific Corporation; Berlin Heart ; Baxter.; Asahi Kasei Medical Co., Ltd.; and ABIOMED. |
Market Segment Insights
Artificial Hearts segment is projected to hold a large market share
Based on types, the Japan artificial organs bionic implants market is segregated into bionics and artificial organs. The bionics segment is further divided into cardiac bionics, orthopedic bionics, vision bionics, and others. The artificial organs segment is further segmented into cochlear implants, artificial lungs, artificial kidneys, artificial hearts, and others. The artificial hearts by artificial organs segment is expected to constitute a key share of the market in the coming years due to a survey, Japan has the greatest percentage of people over the age of 60, having 30% of the population falling into this category. Furthermore, the survey predicts that by 2050, this group would account for 40% of the population. Cardiovascular disease, kidney disease, and neurological issues are just a few of the chronic illnesses that the senior population is prone to. The risk of developing organ failure increases dramatically as one gets older. As a result, Japan's aging population is responsible for driving growth in the artificial organs and bionics market during the forecast period.
Externally worn segment is anticipated to expand at a rapid CAGR
In terms of methods of fixation, the market is segmented into externally worn and implantable. The externally worn segment is expected to represent a key share of the market in the coming years due to growth can be ascribed to the introduction of new upgraded gadgets that are coupled with technological benefits as technology advances.
Mechanical segment is projected to represent a major market share
Based on technology, the Japan artificial organs bionic implants market is bifurcated into electronic and mechanical. The mechanical segment is expected to hold a key share of the market during the forecast period owing to the mechanical artificial heart valves survive significantly longer than conventional choices, resulting in high demand. Fast FDA clearances and reimbursements are also aiding the growth.
Hospital’s segment is expected to register at a significant pace
On the basis of applications, the market is divided into clinical research institutions, hospitals, and others. The hospital’s segment is expected to account for a key share of the market during the forecast period owing to the presence of modern healthcare infrastructure and trained physicians improve procedural adoption rates in the hospitals. The availability of the latest technology in hospitals is driving the growth of the market segment.
Segments
The Japan artificial organs bionic implants market has been segmented based on
Types
- Bionics
- Cardiac Bionics
- Orthopedic Bionics
- Vision Bionics
- Others
- Artificial Organs
- Cochlear Implants
- Artificial Lungs
- Artificial Kidneys
- Artificial Hearts
- Others
- Externally Worn
- Implantable
- Electronic
- Mechanical
- Clinical Research Institutions
- Hospitals
- Others
- Ossur
- Medtronic
- Getinge AB.
- Cyberonics, Inc.
- Cochlear Ltd.
- Boston Scientific Corporation
- Berlin Heart
- Baxter.
- Asahi Kasei Medical Co., Ltd.
- ABIOMED
Competitive Landscape
Key players competing in the Japan artificial organs bionic implants market are Ossur; Medtronic; Getinge AB.; Cyberonics, Inc.; Cochlear Ltd.; Boston Scientific Corporation; Berlin Heart Baxter.; Asahi Kasei Medical Co., Ltd.; and ABIOMED. Some of these players are adopting several business strategies such as acquisitions, mergers, collaborations, partnerships, capacity expansion, and product launches to enhance their market shares.
2. Assumptions and Acronyms Used
3. Research Methodology
4. Artificial Organs Bionic Implants Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Artificial Organs Bionic Implants Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Artificial Organs Bionic Implants Market - Supply Chain
4.5. Global Artificial Organs Bionic Implants Market Forecast
4.5.1. Artificial Organs Bionic Implants Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Artificial Organs Bionic Implants Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Artificial Organs Bionic Implants Market Absolute $ Opportunity
5. Global Artificial Organs Bionic Implants Market Analysis and Forecast by Types
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Types
5.2.2. Y-o-Y Growth Projections by Types
5.3. Artificial Organs Bionic Implants Market Size and Volume Forecast by Types
5.3.1. Bionics
5.3.2. Artificial Organs
5.4. Absolute $ Opportunity Assessment by Types
5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Artificial Organs Bionic Implants Market Analysis and Forecast by Region
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Region
6.2.2. Y-o-Y Growth Projections by Region
6.3. Artificial Organs Bionic Implants Market Size and Volume Forecast by Region
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa (MEA)
6.4. Absolute $ Opportunity Assessment by Region
6.5. Market Attractiveness/Growth Potential Analysis by Region
6.6. Global Artificial Organs Bionic Implants Demand Share Forecast, 2019-2026
7. North America Artificial Organs Bionic Implants Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.2. North America Artificial Organs Bionic Implants Market Size and Volume Forecast by Country
7.2.1. U.S.
7.2.2. Canada
7.3. Absolute $ Opportunity Assessment by Country
7.4. North America Artificial Organs Bionic Implants Market Size and Volume Forecast by Types
7.4.1. Bionics
7.4.2. Artificial Organs
7.5. Basis Point Share (BPS) Analysis by Types
7.6. Y-o-Y Growth Projections by Types
7.7. Market Attractiveness/Growth Potential Analysis
7.7.1. By Country
7.7.2. By Product Type
7.7.3. By Application
7.8. North America Artificial Organs Bionic Implants Demand Share Forecast, 2019-2026
8. Latin America Artificial Organs Bionic Implants Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Latin America Average Pricing Analysis
8.2. Latin America Artificial Organs Bionic Implants Market Size and Volume Forecast by Country
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Absolute $ Opportunity Assessment by Country
8.4. Latin America Artificial Organs Bionic Implants Market Size and Volume Forecast by Types
8.4.1. Bionics
8.4.2. Artificial Organs
8.5. Basis Point Share (BPS) Analysis by Types
8.6. Y-o-Y Growth Projections by Types
8.7. Market Attractiveness/Growth Potential Analysis
8.7.1. By Country
8.7.2. By Product Type
8.7.3. By Application
8.8. Latin America Artificial Organs Bionic Implants Demand Share Forecast, 2019-2026
9. Europe Artificial Organs Bionic Implants Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Europe Average Pricing Analysis
9.2. Europe Artificial Organs Bionic Implants Market Size and Volume Forecast by Country
9.2.1. Germany
9.2.2. France
9.2.3. Italy
9.2.4. U.K.
9.2.5. Spain
9.2.6. Russia
9.2.7. Rest of Europe
9.3. Absolute $ Opportunity Assessment by Country
9.4. Europe Artificial Organs Bionic Implants Market Size and Volume Forecast by Types
9.4.1. Bionics
9.4.2. Artificial Organs
9.5. Basis Point Share (BPS) Analysis by Types
9.6. Y-o-Y Growth Projections by Types
9.7. Market Attractiveness/Growth Potential Analysis
9.7.1. By Country
9.7.2. By Product Type
9.7.3. By Application
9.8. Europe Artificial Organs Bionic Implants Demand Share Forecast, 2019-2026
10. Asia Pacific Artificial Organs Bionic Implants Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Asia Pacific Average Pricing Analysis
10.2. Asia Pacific Artificial Organs Bionic Implants Market Size and Volume Forecast by Country
10.2.1. China
10.2.2. Japan
10.2.3. South Korea
10.2.4. India
10.2.5. Australia
10.2.6. Rest of Asia Pacific (APAC)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Asia Pacific Artificial Organs Bionic Implants Market Size and Volume Forecast by Types
10.4.1. Bionics
10.4.2. Artificial Organs
10.5. Basis Point Share (BPS) Analysis by Types
10.6. Y-o-Y Growth Projections by Types
10.7. Market Attractiveness/Growth Potential Analysis
10.7.1. By Country
10.7.2. By Product Type
10.7.3. By Application
10.8. Asia Pacific Artificial Organs Bionic Implants Demand Share Forecast, 2019-2026
11. Middle East & Africa Artificial Organs Bionic Implants Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Middle East & Africa Average Pricing Analysis
11.2. Middle East & Africa Artificial Organs Bionic Implants Market Size and Volume Forecast by Country
11.2.1. Saudi Arabia
11.2.2. South Africa
11.2.3. UAE
11.2.4. Rest of Middle East & Africa (MEA)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Middle East & Africa Artificial Organs Bionic Implants Market Size and Volume Forecast by Types
11.4.1. Bionics
11.4.2. Artificial Organs
11.5. Basis Point Share (BPS) Analysis by Types
11.6. Y-o-Y Growth Projections by Types
11.7. Market Attractiveness/Growth Potential Analysis
11.7.1. By Country
11.7.2. By Product Type
11.7.3. By Application
11.8. Middle East & Africa Artificial Organs Bionic Implants Demand Share Forecast, 2019-2026
12. Competition Landscape
12.1. Global Artificial Organs Bionic Implants Market: Market Share Analysis
12.2. Artificial Organs Bionic Implants Distributors and Customers
12.3. Artificial Organs Bionic Implants Market: Competitive Dashboard
12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
12.4.1. Ossur
12.4.2. Medtronic
12.4.3. Getinge AB.
12.4.4. Cyberonics, Inc.
12.4.5. Cochlear Ltd.
12.4.6. Boston Scientific Corporation
The Japan artificial organs bionic implants market has been segmented based on
Types
- Bionics
- Cardiac Bionics
- Orthopedic Bionics
- Vision Bionics
- Others
- Artificial Organs
- Cochlear Implants
- Artificial Lungs
- Artificial Kidneys
- Artificial Hearts
- Others
- Externally Worn
- Implantable
- Electronic
- Mechanical
- Clinical Research Institutions
- Hospitals
- Others
- Ossur
- Medtronic
- Getinge AB.
- Cyberonics, Inc.
- Cochlear Ltd.
- Boston Scientific Corporation
- Berlin Heart
- Baxter.
- Asahi Kasei Medical Co., Ltd.
- ABIOMED
Key players competing in the Japan artificial organs bionic implants market are Ossur; Medtronic; Getinge AB.; Cyberonics, Inc.; Cochlear Ltd.; Boston Scientific Corporation; Berlin Heart Baxter.; Asahi Kasei Medical Co., Ltd.; and ABIOMED. Some of these players are adopting several business strategies such as acquisitions, mergers, collaborations, partnerships, capacity expansion, and product launches to enhance their market shares.
Our Clients
Related Reports
Some other reports from this category!
